$2.24
0.094.19%
At close: -
$2.20
-0.04-1.79%
After Hours: Jan 31, 5:20 PM EDT
Comments
Loading...
Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Earnings Estimates, EPS, And Revenue
Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.760
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Salarius Pharmaceuticals (SLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.76 | $-2.40 | 68.3 % |
| Q2 | 2024-08-09 | $-2.37 | $-53.60 | 95.6 % |
| Q1 | 2024-05-13 | $-3.28 | $-53.60 | 93.9 % |
| Q4 | 2024-03-22 | $-1.76 | $-8.08 | 78.2 % |
Salarius Pharmaceuticals (SLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2022-03-10 | $0 | $430.00K | -100.0 % |
| Q3 | 2021-11-04 | $0 | $1.16M | -100.0 % |
| Q2 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
| Q1 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
FAQ
When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?
Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Salarius Pharmaceuticals (NASDAQ:SLRX)?
The Actual EPS was $-0.76, which beat the estimate of $-2.40.
What were Salarius Pharmaceuticals’s (NASDAQ:SLRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.